In contrast, recessive, loss-of-function GALNT3 mutations impair FGF23 actions and thus, like in genetic or autoimmune FGF23 deficiency, lead to familial hyperphosphatemic tumoral calcinosis syndrome (70, 71). The gene discussed is GALNT3; the disease is hyperinsulinemic hypoglycemia, familial, 4.